Search
Library
Log in
Watch fullscreen
9 months ago

Solid Earnings for JNJ Offset Covid-19 Vaccine Trial Setback

The Street
The Street
Johnson & Johnson posts strong third-quarter results and boosts guidance on the same day it announces a pause in its Covid-19 vaccine trial.